https://www.selleckchem.com/products/dooku1.html
57%). All patients were followed-up for 1 year after the procedure. The overall clinical success and periprocedural complication rates were 93.48%, and 15.22% respectively, and 30-day mortality was zero. Clinical success was 92.86% in the coil subgroup (n = 28), and 93.75% in the NBCA glue subgroup (n = 16). The technical success rate was 100%. Effectiveness of the procedures during the follow-up was 97.83%. Target lesion re-intervention rate was 2.17%. Transarterial embolisation can provide high technical and clinical success rates with